Diagnosis of HHV-6 infection using real-time PCR method
Not Applicable
- Conditions
- Recipients of allogeneic stem cell transplantation, including bone marrow, peripheral blood, or cord blood transplantation
- Registration Number
- JPRN-UMIN000032349
- Lead Sponsor
- Department of Hematology, Oita University Hospital.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who didn't agree to participation and patients who were judged as inadequate to participate in this study by the opinion of the investigators.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Positive rate for HHV-6 DNA
- Secondary Outcome Measures
Name Time Method 1. Antiviral agents 2. Association between the results of blood HHV-6 DNA and the development of HHV-6 encephalitis 3. Sensitivity, specificity, positive predictive value, and negative predictive value of positive results for HHV-6 DNA for the diagnosis of HHV-6 encephalitis 4. Association between the results of HHV-6 DNA in cerebrospinal fluid and the development of HHV-6 encephalitis